##common.search##
##search.searchResults##
-
THE ROLE OF BIOIMPEDANCE MONITORING IN HEART FAILURE MANAGEMENT: FROM CONGESTION ANALYSIS TO BODY COMPOSITION ASSESSMENT
Heart failure (HF) remains one of the leading causes of morbidity and mortality worldwide. Frequent hospitalizations impose a substantial burden on healthcare systems, increasing costs and reducing patients’ quality of life [1]. The central pathophysiological mechanism of HF decompensation is fluid retention, which occurs several days before clinical symptoms manifest. This fact has prompted the development of technologies capable of detecting subclinical changes in fluid balance, creating opportunities for early therapy adjustment and prevention of hospitalizations. Among such methods, bioimpedance monitoring—encompassing both thoracic and whole-body analysis—has attracted particular interest, gradually evolving from an experimental technology into a clinically relevant tool.